Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples

Journal of Clinical Virology

Volumn 41, Issue 2, 2008, Pages 134-137

  Reid, Fiona ^a   Hassan, Jaythoon ^a   Irwin, Fiona ^a   Waters, Allison ^a   Hall, William ^a   Connell, Jeff ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Genotype; IgM; Mumps; Vaccine failure

Indexed keywords

IMMUNOGLOBULIN M; MUMPS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS DETECTION; VIRUS ISOLATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; IRELAND; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUMPS; MUMPS VACCINE; MUMPS VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SALIVA; TREATMENT FAILURE;

EID: 38749086443     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.10.009     Document Type: Article

References (21)

1. Broliden K., Abreu E.R., Arneborn M., and Bottinger M. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine 16 (1998) 323-327
2. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Emerg Infect Dis 13 (2007) 12-17
3. Davidkin I., and Valle M. Vaccine induces measles virus antibodies after two doses of combined measles, mumps, and rubella virus vaccine: a 12-year follow-up in two cohorts. Vaccine 16 (1998) 2052-2057
4. Di Renzi M., Jackson S., Gee S., and Cotter S. Increase in mumps in Ireland in late 2004. Eurosurveillance Weekly 8 52 (2004)
5. Jin L., Beard S., and Brown D.W.G. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis 180 (1999) 829-33.7
6. Jin L., Brown D.W.G., Litton P.A., and White J.M. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis 189 (2004) 1001-1008
7. Johnson C., Kumar M.L., Whitwell J.K., et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J 15 (1996) 687-692
8. Miller E., Hill A., Morgan-Capner P., Forsey T., and Rush M. Antibodies to measles, mumps, and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 13 (1995) 799-802
9. Measles Mumps Rubella (MMR) vaccine discussion pack. The Health Board Executive; 2002. p. 1-7.
10. Muhlemann K. The molecular epidemiology of mumps virus. Infect Gen Evol 4 (2004) 215-219
11. Palacios G., Jabado O., Cisterna D., et al. Molecular identification of mumps virus genotypes from clinical samples: standardised method of analysis. J Clin Microbiol 43 (2005) 1869-1878
12. Perry K.R., Brown D.W.G., Parry J.V., Panday S., Pipkin C., and Richards A. Detection of measles, mumps and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 40 (1993) 235-240
13. Posada D., and Crandall K.A. Modeltest: testing the model of DNA substitution. Bioinformatics 14 (1998) 817-818
14. Rubin S., Maudlin J., Chumakov K., and Vanderzanden J. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24 (2006) 2662-2668
15. Sanz-Moreno J.C., Limia-Sanchez A., and Garcia-Comas L. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G. Vaccine 23 (2005) 4921-4925
16. Sugiura A., and Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis 10 (1991) 209-213
17. Swofford D.L. PAUP*. Phylogenetic analysis using parsimony (* and other methods). 4.0b10 ed. (2002), Sinauer Associates Inc., Sunderland, MA, USA
18. Tecle T., Bottinger B., Orvell C., and Johansson B. Characterisation of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J Gen Virol 82 (2001) 2675-2680
19. Utz S., Richard J., Capaul S., Matter H.C., and Hirisoho G.M. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and un-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000. J Virol 73 (2004) 91-96
20. Vandermeulen C., Roelants M., Vermoere M., Roseeuw K., Goubau P., and Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure?. Vaccine 22 (2004) 2713-2716
21. Weibel R.E., Buynak E.B., McLean A.A., Roehm R.R., and Hilleman M.R. Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines. Proc Soc Exp Biol Med 165 (1980) 260-263